Abstract:The G protein-coupled receptor, family C, group 5, member A (GPRC5A), a retinoic acid induced gene expressed primarily in human and mouse lung tissue. Our previous studies demonstrated that mice with a deletion of the Gprc5a gene develop spontaneous lung adenomas and adenocarcinomas. Since Gprc5a is expressed preferentially in epithelial cells in lung tissues, we isolated epithelial cells from tracheas of Gprc5a+/+ and Gprc5a−/− mice and used them for an analysis of phenotypic and genotypic differences that might explain the mechanisms of Gprc5a actions. We found that normal Gprc5a−/− cells can survive better than Gprc5a+/+ cells in basal medium deprived of supplemented growth factors. Furthermore, the Gprc5a−/− cells but not the Gprc5a+/+ cells were able to form colonies in semi-solid medium. To explore possible mechanisms that underlay the distinct phenotypes of the above cells, we compared and contrasted the survival signaling pathway mediated by the Signal Transducer and Activator of Transcription 3 (STAT3), which is triggered by certain cytokines and growth factors to regulate the expression of genes implicated in cell growth differentiation, survival, inflammation and transformation. Increased Stat3 activity by phosphorylation has been identified in a variety of tumors including non-small cell lung cancers (NSCLCs) and it has been linked to inflammation and tumor progression. The constitutive activity (phosphorylation of tyrosine 705) of Stat3 and the expression of several Stat3 regulated genes including survivin, Bcl-XL, and Mcl1 at both the mRNA and protein levels was higher in the Gprc5a−/− cells compared to normal Gprc5a+/+ cells. Stat3 activation was triggered by autocrine Leukemia inhibitory factor (Lif), a member of the interleukine-6 (IL-6) family of cytokines, as revealed after adding neutralizing antibodies against different Stat3 activating cytokines to the growth medium. Although Gprc5a+/+ cells produced and secreted sufficient amounts of Lif into their conditioned medium, their response to Lif was transient, whereas the Gprc5a−/− cells showed a prolonged response evidenced by a persistent Stat3 activation. Lung cancer cells isolated from an adenocarcinorma of Gprc5a−/− mice exhibited Lif-mediated Stat3 activation similar to the normal Gprc5a−/− cells. Blocking Stat3 activation using AG490, an inhibitor of Stat3 signaling, or using a dominant negative Stat3 (mutant Y705F) in the Gprc5a−/− normal and cancer cells increased apoptosis and inhibited anchorage-independent growth. These results demonstrate that Stat3 activation may be important for the early stages of lung tumorigenesis in Gprc5a−/− mice and by implication that the tumor suppressive effects of Gprc5a are mediated, at least in part, by suppression of Stat3 signaling. Supported in part by the Samuel Waxman Cancer Research Foundation. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 4995.

Deregulation of PRDM5 promotes cell proliferation by regulating JAK/STAT signaling pathway through SOCS1 in human lung adenocarcinoma

The Epigenetic Modifier PRDM5 Functions As a Tumor Suppressor Through Modulating WNT/β-catenin Signaling and is Frequently Silenced in Multiple Tumors.

PRMT5 Enables Robust STAT3 Activation via Arginine Symmetric Dimethylation of SMAD7

PDLIM5 Inhibits STUB1-mediated Degradation of SMAD3 and Promotes the Migration and Invasion of Lung Cancer Cells.

Silencing of PRDM5 Increases Cell Proliferation and Inhibits Cell Apoptosis in Glioma

Aberrant Expression of SCARA5 in Lung Adenocarcinoma and its Clinical Significance

Gprc5a Deletion Enhances the Transformed Phenotype in Normal and Malignant Lung Epithelial Cells by Eliciting Persistent Stat3 Signaling Induced by Autocrine Leukemia Inhibitory Factor.

Restoration of SOCS3 Suppresses Human Lung Adenocarcinoma Cell Growth by Downregulating Activation of Erk1/2, Akt Apart from STAT3

SOX5 Predicts Poor Prognosis in Lung Adenocarcinoma and Promotes Tumor Metastasis Through Epithelial-Mesenchymal Transition

Krüppel-Like Factor 5 Promotes Lung Tumorigenesis Through Upregulation of Sox4

GPRC5A Deficiency Leads to Dysregulated MDM2 Via Activated EGFR Signaling for Lung Tumor Development

Abstract 4995: Loss of the Lung-Specific Tumor Suppressor Gprc5a Causes Persistent Activation of Stat3 Leading to Increased Survival Signaling in Normal and Malignant Lung Epithelial Cells

Lung Tumor Suppressor GPRC5A Binds EGFR and Restrains Its Effector Signaling.

Protein arginine methyltransferase 5 regulates multiple signaling pathways to promote lung cancer cell proliferation

Suppression of Tumorigenesis in LUAD by LRP1B Through Regulation of the IL-6-JAK-STAT3 Pathway.

PRMT5 activates KLF5 by methylation to facilitate lung cancer

Ros-Mediated Hypomethylation Of Prdx5 Promotes Stat3 Binding And Activates The Nrf2 Signaling Pathway In Nsclc

c5a Deletion Enhances the Transformed Phenotype in mal and Malignant Lung Epithelial Cells by Eliciting sistent Stat3 Signaling Induced by Autocrine

Regulatory mechanism and expression level of PRPS2 in lung cancer

Decreased expression of RPS15A suppresses proliferation of lung cancer cells

PRMT5 Inhibition Promotes PD-L1 Expression and Immuno-Resistance in Lung Cancer